Unraveling pacemaker (dys)function using novel stem cell-derived human heart models

This project aims to enhance understanding of sinoatrial node function and its dysfunction in heart rhythm disorders using innovative in vitro models derived from human pluripotent stem cells.

Subsidie
€ 1.797.105
2024

Projectdetails

Introduction

The pacemaker cells of the sinoatrial node (SAN) trigger three billion heartbeats in an average human lifespan. At the start of each beat, the SAN must generate enough current to drive the surrounding atrial tissue, which contains 10,000 times as many cells as the SAN itself.

Biological Mechanisms

This extraordinary biological feat is a result of intrinsic features such as SAN tissue architecture. In addition, SAN function is modulated by extrinsic inputs from the autonomic nervous system, which adjusts the pace from beat-to-beat, for example during exercise.

SAN Dysfunction

Any disturbances to these core activities result in SAN dysfunction, which includes:

  • Abnormal heart rate (brady or tachycardias)
  • SAN exit block (lack of atrial activation)
  • Chronotropic incompetence (inability to increase heart rate)

SAN dysfunction is also a major trigger for atrial fibrillation, the most common form of arrhythmia.

Research Goals

The goal of this ERC-StG proposal is to make significant leaps in our understanding of the intrinsic and extrinsic factors that regulate SAN function in health and disease using innovative multi-cell type as well as multi-organ in vitro models created from human pluripotent stem cells.

Objectives

  1. Role of SAN Subpopulations: Determine the role of SAN subpopulations, particularly transitional cells, in facilitating impulse propagation at the pacemaker-atrial interface by evaluating an SCN5A loss-of-function mutation.

  2. Insights into SAN Dysfunction and Atrial Fibrillation: Gain insights into the relationship between SAN dysfunction and atrial fibrillation by assessing MYH6 variants associated with both these diseases.

  3. Impact of Neurodegenerative Diseases: Unravel how damage to autonomic function in the higher orders of the brain, for example, in neurodegenerative diseases such as Huntington’s, disrupts the electrical activity of pacemaker cells.

Conclusion

This research will provide exquisite knowledge of the fundamental principles that regulate pacemaker function, which is essential to effectively address SAN dysfunction and atrial arrhythmias.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.797.105
Totale projectbegroting€ 1.797.105

Tijdlijn

Startdatum1-5-2024
Einddatum30-4-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • STICHTING AMSTERDAM UMCpenvoerder

Land(en)

Netherlands

Vergelijkbare projecten binnen European Research Council

ERC Advanced...

Advanced human models of the heart to understand cardiovascular disease

Heart2Beat aims to develop innovative 3D human cardiac models using microfluidic technology to enhance understanding and treatment of cardiovascular diseases through personalized medicine.

€ 2.500.000
ERC Consolid...

Translational optoelectronic control of cardiac rhythm in atrial fibrillation

This project aims to develop a shock-free, optoelectronic method for controlling cardiac rhythm in atrial fibrillation using engineered 3D heart models and advanced monitoring systems.

€ 1.999.999
ERC Advanced...

Programming the EPIcardium to CURE broken hearts

EPICURE aims to decode human epicardial development and regeneration using pluripotent stem cell-derived epicardioids, enhancing insights for cardiac repair through advanced imaging and CRISPR techniques.

€ 2.499.999
ERC Advanced...

Unique non-invasive pace-mapping system to identify subjects at risk of arrhythmic sudden death

Develop a non-invasive mapping and pacing system to detect cardiac signals for predicting sudden cardiac death, improving early diagnosis and management of heart disease.

€ 2.488.400
ERC Starting...

Harnessing Novel Micropeptides in Cardiomyocytes to promote Cardiac Regeneration

Novel.CaRe aims to enhance cardiac regeneration post-myocardial infarction by using micropeptides to stimulate cardiomyocyte proliferation and maturation through innovative gene therapy approaches.

€ 1.592.281

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

NaV1.5 regulation fine-tuning as a therapy for cardiac Conduction and Arrhythmic diseases at Risk of suddEn Death

The NaV1.5-CARED consortium aims to develop innovative therapies for cardiac arrhythmias by identifying genetic factors and therapeutic targets to restore NaV1.5 function and personalize risk assessment.

€ 4.546.205
EIC Pathfinder

Engineering a living human Mini-heart and a swimming Bio-robot

The project aims to develop advanced in vitro human cardiac models, including a vascularized mini-heart and a bio-robot, to better assess cardiotoxicity and improve understanding of cardiovascular disease.

€ 4.475.946
EIC Pathfinder

Cardiogenomics meets Artificial Intelligence: a step forward in arrhythmogenic cardiomyopathy diagnosis and treatment

The project aims to integrate genomics, proteomics, and structural analyses to clarify genotype-phenotype relationships in arrhythmogenic cardiomyopathy, paving the way for novel therapies.

€ 3.740.868